Navigation Links
2010 Recipient of Minority Scholar Award Will Conduct Clinical Research on Leukemia

WASHINGTON, March 9 /PRNewswire-USNewswire/ -- Alison Walker, MD, has been selected to receive the ASH-AMFDP Award, and will begin her research in acute myeloid leukemia in July of this year. The award, designed to help increase the number of underrepresented minority scholars in the field of hematology, is the result of a partnership between the American Society of Hematology (ASH) and the Harold Amos Medical Faculty Development Program (AMFDP) of the Robert Wood Johnson Foundation. It provides four years of support, including an annual stipend of up to $75,000 and an annual grant of $30,000 to support research activities.

"To have been selected as the 2010 recipient of the ASH-AMFDP award is truly an honor," said Dr. Walker. "The opportunities for career development made possible by this award are many, and I look forward to working with both ASH and the AMFDP in the years to come."

Dr. Walker is the fourth recipient of the ASH-AMFDP award. Her research, "Targeting the Expression of Mutated Genes Encoding Tyrosine Kinases in Acute Myeloid Leukemia (AML)," will explore the effect of both direct and indirect inhibition of aberrant tyrosine kinase activity as part of a phase I clinical trial in patients with relapsed or refractory AML. The correlative science that results from this clinical trial will allow Dr. Walker to identify mechanisms of leukemogenesis and further her efforts in the development of experimental therapeutics for patients with this disease.

Dr. Walker is currently Assistant Professor of Internal Medicine, Division of Hematology and Oncology, The Ohio State University Medical Center, Columbus, OH.

For more information about this award, please visit the ASH-AMFDP page on the ASH Web site.

To arrange an interview with Dr. Walker, please contact Patrick C. Irelan, ASH Communications Assistant, at 202-776-0544 or

The American Society of Hematology ( is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. ASH provides Blood: The Vital Connection (, a credible online resource addressing bleeding and clotting disorders, anemia, and cancer. The official journal of ASH is Blood (, the most cited peer-reviewed publication in the field, which is available weekly in print and online.

SOURCE American Society of Hematology

Back to top



SOURCE American Society of Hematology
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. 2010 recipient of Minority Scholar Award will conduct clinical research on leukemia
2. The Association of Diversity Councils Announces Its 2010 Diversity Council Honors Award™ Recipients
3. New drug for kidney transplant recipients effective in humans
4. Alexander Graham Bell Association for the Deaf and Hard of Hearing Announces 2010 Award Recipients
5. Autism Science Foundation Announces 2010 Doctoral Training Award Recipients
6. Estes Audiology Awards Hearing Aids to Two Worthy Recipients in Central Texas
7. Southwest Airlines Announces Recipients of its 2010 Medical Transportation Grant Program
8. Jamie Oliver, Chef and International Nutrition Advocate, Named Recipient of 2010 TED Prize
9. Center to Advance Palliative Care Director and MacArthur Recipient, Diane E. Meier, MD, Accepts Fellowship Post With Senate HELP Committee
10. Heartland Health Named 2009 Baldrige Award Recipient
11. Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients
Post Your Comments:
(Date:6/27/2016)... ... 2016 , ... The OSHA Training Center at Chabot-Las ... headquartered in Northern California, has issued an important reminder to employers to prevent ... Employers with workers exposed to high temperatures should establish a complete heat illness ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal ... Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Cut Pro X users can now reveal the media of their split screens ...
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is ... emergency ambulance transport experience for the millions of people who require these medical ... the taxi industry through the use of technology. Now, SmartEMS has put forth ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
Breaking Medicine Technology: